Kezar Life Sciences

12/21/2023

As the year draws to a close, we want to take a moment to extend our warmest wishes to you and your loved ones. We hope this time brings you peace and joy.

11/22/2023

This , Kezar wishes to express heartfelt gratitude. To patients who inspire us daily with their courage, to patient advocacy groups championing the cause, to our collaborating physicians for their dedication, and to our unwavering team: Thank you. Your trust, collaboration, and resilience drive us to advance novel therapies for immune-mediated and oncologic disorders. We are thankful for each one of you as we journey together toward a brighter, healthier future.

11/16/2023

Discover more about PORTOLA, a study evaluating , an investigational drug as a potential new treatment for AIH, and access further study details here: kezarlifesciences.com/patients/clinical-trials

10/20/2023

Join us in supporting the fight against at two important events this weekend:

Kezar is proud to be an Exhibitor Sponsor at the Lupus Research Alliance – ManyOne Can Walk to Cure Lupus in Dallas on Oct 21.

We're also participating in the Lupus Foundation of America’s – 2023 Walk to End Lupus Now in San Francisco on Oct 22.

Together, let's take strides towards a lupus-free future.

Learn More:
https://give.lupusresearch.org/event/2023-dallas-walk-with-us-to-cure-lupus/e475340

https://support.lupus.org/site/TR/WTELN/General?pg=entry&fr_id=1932

09/28/2023

Our Phase 2b trial is actively enrolling people living with ( ). Learn about our patient-centric approach and more on the trial here: https://palizadetrial.com/

09/26/2023

Join us TODAY (Tuesday, Sept. 26) from 12-1 p.m. ET for an educational webinar sponsored by Kezar Life Sciences, “The Truth About Clinical Trials: Debunking Four Common Myths."

Use this link to join the webinar: https://iu.zoom.us/j/85265740704

Dr. Ethan Weinberg, a site Principal Investigator for the PORTOLA Clinical Trial, will lead a talk aiming to:

• Shed light on common myths about clinical trials
• Highlight the facts around clinical trial participation
• Explain how Kezar’s investigational product, zetomipzomib (KZR-616) may be able to help people living with AIH in the PORTOLA clinical trial.

More information about the PORTOLA trial can be found
here: https://clinicaltrials.gov/ct2/show/NCT05569759

The PORTOLA clinical trial (NCT05569759) aims to enroll patients who have not fully responded to standard treatments or who are experiencing flares of liver inflammation on standard treatments. Standard treatments for AIH have not advanced in more than 50 years, and the AIHA is excited that Kezar recognizes the need for new therapies for patients.

The webinar is sponsored by Kezar Life Sciences and the AIHA.

09/21/2023

We’re proud to announce our strategic partnership with Everest Medicines to develop for the treatment of lupus nephritis and other potential indications in Greater China, South Korea , and Southeast Asia.

Read more about our new partnership here: https://ir.kezarlifesciences.com/news-releases/news-release-details/kezar-life-sciences-and-everest-medicines-enter-agreement

09/20/2023

Don’t miss our CMO, Noreen R. Henig’s, M.D, panel discussion on patient-centric clinical trials at the HealthLeaders Pharma NOW Summit today. Register for today’s event here: https://event.on24.com/eventRegistration/EventLobbyServlet?target=reg20.jsp&eventid=2316043&sessionid=1&key=C43345E26DB1E1C464082F44BC6FC8A2&groupId=1695635&partnerref=hlsite&sourcepage=register

This week, our CMO, Noreen R. Henig, M.D., will participate in a panel, “Patients First – Including Patients in the Design of Clinical Trials,” at the virtual HealthLeaders Pharma NOW Summit. Register for the event here: https://event.on24.com/eventRegistration/EventLobbyServlet?target=reg20.jsp&eventid=2316043&sessionid=1&key=C43345E26DB1E1C464082F44BC6FC8A2&groupId=1695635&partnerref=hlsite&sourcepage=register

09/19/2023

We are excited to introduce the new PALIZADE clinical trial website. Learn more about zetomipzomib, an investigational agent under study as a potential treatment for adults living with ( ). Dive into the details of the trial here: https://palizadetrial.com

09/18/2023

This week, our CMO, Noreen R. Henig, M.D., will participate in a panel, “Patients First – Including Patients in the Design of Clinical Trials,” at the virtual HealthLeaders Pharma NOW Summit. Register for the event here: https://event.on24.com/eventRegistration/EventLobbyServlet?target=reg20.jsp&eventid=2316043&sessionid=1&key=C43345E26DB1E1C464082F44BC6FC8A2&groupId=1695635&partnerref=hlsite&sourcepage=register

08/29/2023

There are limited effective treatment options for patients with . Join us in our mission to improve the lives of those living with lupus nephritis and learn about our Trial here: https://kezarlifesciences.com/patients/clinical-trials

08/25/2023

With over 30 years of experience in the development of drug products, our VP of Pharmaceutical Development, Rafael Sarabia, Ph.D., has led teams through the successful commercialization of multiple products. Learn about why he joined Kezar and more on his role: https://kezarlifesciences.com/about/team